Keep up to date with every new upload!

Join free & follow CME
Share
Innovations in the Management of Dyspareunia

Innovations in the Management of Dyspareunia

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Guest: David J. Portman, MD

Vulvar vaginal atrophy (VVA) affects about half of the 64 million postmenopausal women in the U.S. VVA is the loss of estrogen stimulation on vaginal and vulvar tissue, resulting in atrophy of these tissues and these women may suffer from symptoms, which include dyspareunia - or painful sexual intercourse. With this, dyspareunia can negatively impact a woman’s sexual function and sexual relationships, in addition to her overall quality of life. This interview will focus on the diagnosis of dyspareunia and the therapies indicated for the management of this condition.

Comments